Navigation Links
Groups Join Forces to Fund Promising Lung Cancer Research

Two health groups are joining forces to fund three promising lung cancer researchers. The LUNGevity Foundation and the American Cancer Society// are contributing $370,000 to fund the first-ever LUNGevity Foundation and American Cancer Society Lung Cancer Postdoctoral Fellowships. The grants will go to three researchers whose novel approaches may help improve the understanding of how lung cancer develops and could lead to more effective treatments.

The new collaboration will fund three promising research grant applications, grants that passed a rigorous peer review process but could not be funded because of a shortfall of available funds. The three post-doctoral researchers who will receive support are:

?Timothy K. Starr, PhD, University of Minnesota, Twin Cities, whose work on the "Sleeping Beauty transposase” will identify genes specifically involved in lung tumor formation;

?Steven P. Zielske, PhD, University of Michigan, who hopes to modify special cells so they can deliver high concentrations of chemotherapy to lung tumors; and

?Dwight Seferos, PhD, Northwestern University, who will develop a strategy to use nanoparticles to deliver a highly concentrated package of therapies to a specific cellular target.

"It gives us great satisfaction to see these promising researchers get the support they deserve,” said John Stevens, MD, American Cancer Society vice president of extramural grants. "These new fellowships join 76 other multi-year lung cancer research grants totaling more than $42 million the Society currently funds, as we continue to look for answers to improve the lives and prognoses for patients with this top cause of cancer death in the United States.”

"These fellowships are a wonderful opportunity for LUNGevity to continue our support for the most promising lung cancer research,” said Jill Feldman, president of the LUNGevity Foundation. "We are determined to invest in this type of leading-edge research until a cure can be found to treat the 200,000 American diagnosed with lung cancer each year.” Funding for the grants was also provided by a generous estate gift from Catherine and Timothy Fitzgerald to the American Cancer Society.

The American Cancer Society is dedicated to eliminating cancer as a major health problem by saving lives, diminishing suffering and preventing cancer through research, education, advocacy and service. Founded in 1913 and with national headquarters in Atlanta, the Society has 13 regional Divisions and local offices in 3,400 communities, involving millions of volunteers across the United States.

As the pioneer organization dedicated to lung cancer research, LUNGevity Foundation is the leading private provider of research funding for the nation's number one cancer killer. The Foundation's goal is to save the lives of the 200,000 Americans newly diagnosed with lung cancer each year, eighty-five percent of whom will die within five years without the development of new treatment methods. Partnering with the foremost physicians and research scientists in the world, the LUNGevity Foundation funds innovative research designed to treat and cure lung cancer. Source: American Cancer Society
SM/B
'"/>




Related medicine news :

1. Yogic Moments: Age Old Yoga, Benefits All Age Groups
2. Plastic Surgery Is Primetime among Ethnic Groups
3. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
4. Specialist Services Can Help Ethnic Groups To Tackle Alcohol Misuse
5. Distinct Support Services Needed, To Resurrect Ethnic Groups from Alcohol Abuse
6. NGOs and Various Groups Come Together To Address the Issues on AIDS
7. Anti-Obesity Groups Criticize Response of Medical Professionals
8. Hospitals Appeal to Citizen Groups to Rush Doctors, Paramedicals
9. Corporate Groups To Participate In Jharkhand Health Care Scheme
10. Incompatible Blood Groups Not A Hurdle For Kidney Transplant
11. Kids From Low-Income Groups Could Enhance Their Nutrition By Choosing Better After School Snacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/29/2016)... ... , ... Whole Health Supply is happy to announce the favorable reception of ... This new style of nail clipper has a wider jaw opening that is useful ... the actual handle is 2.5mm thick to accommodate the cutting force. This is the ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can ... drop a preset onto their media," said Christina Austin - CEO of Pixel Film ... can quickly and easily add stylish color grades to their footage. A LUT is ...
(Date:5/27/2016)... CA (PRWEB) , ... May 27, 2016 , ... More ... Health, so it is not surprising that bariatric surgery has received increased attention in ... Journal explains. Of course, when it comes to weight loss, most people are familiar ...
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... An ... returns for a third time to shed lights on the variety of topics detailing ... inspirational stories, “Nurse Appreciation” tackles why this career has gone from being in a ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... partnered with Mediaplanet to help educate the many who are unaware of the ... dedicated to aphasia will run within the “Stroke Awareness” campaign. , The link ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 MedDay, ... disorders, announces that an oral presentation entitled "High doses of ... MS-SPI trial" will be given by Professor Ayman Tourbah ... 2nd Congress of the European Academy of Neurology (EAN) in ... and related disorders 3" will take place on Sunday, 29 ...
(Date:5/24/2016)... , May 24, 2016 ... Markt gebracht, die es Ärzten erlaubt, ihre Expertise ... behandeln: MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion ... zu kommunizieren. Mediziner in Europa, Afrika, Asien und ... bereits für die Plattform registriert. Information ...
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
Breaking Medicine Technology: